Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 11/20 | 0.56 |
| ▸ | RAB9A | P51151 | 9/20 | 0.56 |
| ▸ | MAPT | P10636 | 5/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.56 |
| ▸ | ATM | Q13315 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 10/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | CASP1 | P29466 | 2/20 | 0.44 |
| ▸ | CASP7 | P55210 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | APAF1 | O14727 | 1/20 | 0.44 |
| ▸ | STAT1 | P42224 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6930071 | 0.88 | MEN1 (0.58) | NPC1RAB9AMAPTKDM4EATM | |
| SCHEMBL2800533 | 0.84 | MAPT (0.41) | NPC1RAB9AMAPTKDM4EATM | |
| SCHEMBL30383298 | 0.84 | MAPT (0.41) | NPC1RAB9AMAPTKDM4EATM | |
| SCHEMBL9552155 | 0.84 | MEN1 (0.53) | NPC1RAB9AMAPTKDM4EATM | |
| SCHEMBL3937549 | 0.82 | NPC1 (0.51) | NPC1RAB9AMAPTKDM4EATM | |
| SCHEMBL30058950 | 0.82 | NPC1 (0.51) | NPC1RAB9AMAPTKDM4EATM | |
| SCHEMBL7785471 | 0.82 | MEN1 (0.51) | NPC1RAB9AMAPTKDM4EATM | |
| SCHEMBL9638363 | 0.82 | NPC1 (0.53) | NPC1RAB9AMAPTKDM4EATM | |
| SCHEMBL10441256 | 0.82 | NPC1 (0.56) | NPC1RAB9AMAPTKDM4EATM | |
| SCHEMBL3782539 | 0.80 | POLB (0.50) | NPC1RAB9AMAPTKDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12486239-B2 | Benzotriazole compound, light absorber, and resin composition | MITSUI CHEMICALS, INC. (JP) | 2025-12-02 | — | — | US | disclosed |
| EP-4435499-A2 | BENZOTRIAZOLE COMPOUND, LIGHT ABSORBER, AND RESIN COMPOSITION | Mitsui Chemicals, Inc. (JP) | 2024-09-25 | — | — | EP | disclosed |
| CN-114423742-B | Benzotriazole-based compound, light absorber and resin composition | 三井化学株式会社 | 2024-05-28 | — | — | CN | disclosed |
| CN-117466830-A | Benzotriazole-based compound, light absorber and resin composition | 三井化学株式会社 | 2024-01-30 | — | — | CN | disclosed |
| US-20220363650-A1 | BENZOTRIAZOLE COMPOUND, LIGHT ABSORBER, AND RESIN COMPOSITION | MITSUI CHEMICALS, INC. (JP) | 2022-11-17 | — | — | US | disclosed |
| EP-4032879-A1 | BENZOTRIAZOLE COMPOUND, LIGHT ABSORBER, AND RESIN COMPOSITION | Mitsui Chemicals, Inc. (JP) | 2022-07-27 | — | — | EP | disclosed |
| CN-114423742-A | Benzotriazole compound, light absorber, and resin composition | 三井化学株式会社 | 2022-04-29 | — | — | CN | disclosed |
| WO-2021054459-A1 | BENZOTRIAZOLE COMPOUND, LIGHT ABSORBER, AND RESIN COMPOSITION | 三井化学株式会社 | 2021-03-25 | — | — | WO | disclosed |
| EP-0944624-B1 | INSOLUBLE S-TRIAZINE DERIVATIVES AND THEIR USE AS UV FILTERS | OREAL (FR) | 2003-11-05 | — | — | EP | disclosed |
| CN-1123572-C | Insoluble s-triazine derivatives, process for their preparation, compositions containing them and their use | OREAL (FR) | 2003-10-08 | — | — | CN | disclosed |
| EP-0841341-A1 | Sunscreen agents, and cosmetic compositions containing them | L'OREAL (FR) | 1998-05-13 | — | — | EP | disclosed |
| US-5206378-A | Ultraviolet light stabilizers | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1993-04-27 | — | — | US | disclosed |
| EP-0303986-B1 | MULTIPURPOSE POLYMER BOUND STABILIZERS | ATOCHEM NORTH AMERICA, INC. (US) | 1992-07-29 | — | — | EP | disclosed |
| US-5096974-A | Reacting primary amino or hydrazido-substituted stabilizers with maleic anhydride polymers; nonextractable and nonvolatile in polymer blends | ATOCHEM NORTH AMERICA, INC. (US) | 1992-03-17 | — | — | US | disclosed |
| US-5096977-A | Anhydride polymers | ATOCHEM NORTH AMERICA, INC. (US) | 1992-03-17 | — | — | US | disclosed |
| US-4981915-A | HYDRAZIDE MODIFIERS | ATOCHEM NORTH AMERICA, INC. (US) | 1991-01-01 | — | — | US | disclosed |
| US-4981914-A | HYDRAZIDE MODIFIERS | ATOCHEM NORTH AMERICA, INC. (US) | 1991-01-01 | — | — | US | disclosed |
| US-4868246-A | PRIMARY AMINO OR HYDRAZIDO UV ABSORBERS CHEMICALLY BOUND TO POLYMER ANHYDRIDE GROUPS | PENNWALT CORPORATION (US) | 1989-09-19 | — | — | US | disclosed |
| US-4863999-A | IMIDES OR AMIC ACIDS OF ANHDRIDE POLYMERS | PENNWALT CORPORATION (US) | 1989-09-05 | — | — | US | disclosed |
| EP-0303986-A2 | Multipurpose polymer bound stabilizers | ATOCHEM NORTH AMERICA, INC. (US) | 1989-02-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220363650-A1 | BENZOTRIAZOLE COMPOUND, LIGHT ABSORBER, AND RESIN COMPOSITION | SULT1A1, BET1, SULT1E1 | NPC1 2214/4885RAB9A 4544/4885MAPT 790/4885 |
| US-12486239-B2 | Benzotriazole compound, light absorber, and resin composition | SULT1A1, BET1, SULT1E1 | NPC1 2214/4885RAB9A 4544/4885MAPT 790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.